• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    MultiCell Technologies, Inc. (MCET)

    -Other OTC
    0.00 0.00(0.00%) Jul 2, 10:58AM EDT
    Add to Portfolio
    ProfileGet Profile for:
    MultiCell Technologies, Inc.
    68 Cumberland Street
    Suite 301
    Woonsocket, RI 02895
    United States - Map
    Phone: 401-762-0045
    Website: http://www.multicelltech.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Biotechnology
    Full Time Employees:2

    Business Summary 

    MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. Its product portfolio comprise MCT-125, a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue; MCT-465, a preclinical synthetic double-stranded RNA (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers; MCT-475, a discovery stage antibody therapeutic candidate used in combination with dsRNA for the treatment of solid tumor cancers; and MCT-485, a discovery stage dsRNA therapeutic candidate with tumor cytolytic properties for the treatment of various cancers. The company also develops Ideal BioStent, a bioabsorbable stent for interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. has a license agreement with Corning Incorporated and Pfizer Inc. The company was formerly known as Exten Industries, Inc. and changed its name to MultiCell Technologies, Inc. in April 2004. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on MultiCell Technologies, Inc.

    Key Executives 
     PayExercised
    Mr. W. Gerald Newmin , 78
    Chairman, Chief Exec. Officer, Pres, Chief Financial Officer, Treasurer and Sec.
    182.00K0.00
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders